Strides Arcolab gets nod from US FDA for Vancomycin Capsules

11 Apr 2012 Evaluate

Strides Arcolab (Strides) has received approval from the US FDA for Vancomycin Hydrochloride Capsules USP, 125 mg and 250 mg. Vancomycin Capsules had total US sales of $32 million for the twelve months ending February 2012, with no prior generic approvals.

Vancomycin Hydrochloride Capsules is glycopeptides antibiotic used in the prophylaxis and treatment of infections caused by Gram positive bacteria. It has traditionally been reserved as a drug of last resort used only after treatment with other antibiotics had failed.

Strides Arcolab is a global pharmaceuticals headquartered in Bangalore, India that develops and manufactures a wide range of IP-led niche pharmaceuticals products with an emphasis on sterile injectables. 

Strides Pharma Scien Share Price

675.30 -9.00 (-1.32%)
23-Dec-2024 10:12 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1811.10
Dr. Reddys Lab 1344.30
Cipla 1472.00
Lupin 2157.80
Zydus Lifesciences 969.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.